Skip to content

Clinical trials

Completed Phase 1/2 Skin Neoplasms trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Skin Neoplasms Phase: Phase 1/2 Status: Completed Clear all

14 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20062
20071
20081
20091
20101
20132
20151
20161
20171
20181
20191

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed14

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Allarity Therapeutics1
Ascend Biopharmaceuticals Ltd1
Hussein Tawbi1
Klus Pharma Inc.1
Ludwig Institute for Cancer Research1
Medical Dermatology Specialists1
National Cancer Institute (NCI)1
NewLink Genetics Corporation1
Nina Bhardwaj1
Revolution Medicines, Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Skin Neoplasms14
Melanoma7
Neoplasms6
Lung Neoplasms3
Ovarian Neoplasms3
Pancreatic Neoplasms3
Prostatic Neoplasms3
Basal Cell Carcinoma2
Breast Neoplasms2
Carcinoma, Non-Small-Cell Lung2

Trials

Showing 1 to 14 of 14. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.